Akarsu, E. Et Al. 1999. Prevalance of Hepatilis-C Virus Anti-Body in Hemodialysis Patients: Effects of Blood Transfusions and Dialysis Duration. Eurasian Journal of Medicine , vol.31 , 7-10.

Akarsu, E., Tonbul, H. Z., Selçuk, Y., KAYA, H., & ÇETİNKAYA, R., (1999). Prevalance of Hepatilis-C Virus Anti-Body in Hemodialysis Patients: Effects of Blood Transfusions and Dialysis Duration. Eurasian Journal of Medicine , vol.31, 7-10.

Akarsu, Ersin Et Al. "Prevalance of Hepatilis-C Virus Anti-Body in Hemodialysis Patients: Effects of Blood Transfusions and Dialysis Duration," Eurasian Journal of Medicine , vol.31, 7-10, 1999

Akarsu, Ersin Et Al. "Prevalance of Hepatilis-C Virus Anti-Body in Hemodialysis Patients: Effects of Blood Transfusions and Dialysis Duration." Eurasian Journal of Medicine , vol.31, pp.7-10, 1999

Akarsu, E. Et Al. (1999) . "Prevalance of Hepatilis-C Virus Anti-Body in Hemodialysis Patients: Effects of Blood Transfusions and Dialysis Duration." Eurasian Journal of Medicine , vol.31, pp.7-10.

@article{article, author={Ersin Akarsu Et Al. }, title={Prevalance of Hepatilis-C Virus Anti-Body in Hemodialysis Patients: Effects of Blood Transfusions and Dialysis Duration}, journal={Eurasian Journal of Medicine}, year=1999, pages={7-10} }